Table 4.
HO-CDI vs. All non HO-CDI | PD-CDI vs. All non HO-CDI | |||
---|---|---|---|---|
Individual Variables | OR (95% CI) | p-value | OR (95% CI) | p-value |
Age | <0.001 | <0.001 | ||
18 – < 40 | Reference | Reference | ||
40 – 49 | 1.93 (1.29–2.89) | 2.20 (1.53–3.17) | ||
50 – 59 | 1.82 (1.23–2.71) | 2.21 (1.54–3.17) | ||
60 – < 75 | 1.83 (1.28–2.61) | 2.76 (1.99–3.82) | ||
75+ | 2.16 (1.51–3.09) | 3.93 (2.85–5.44) | ||
Male Gender | 1.04 (0.93–1.16) | 0.49 | 0.87 (0.80–0.95) | 0.001 |
Race | 0.01 | <0.001 | ||
White | Reference | Reference | ||
Black | 0.94 (0.61–1.45) | 0.49 (0.31–0.78) | ||
Asian | 1.27 (1.06–1.52) | 0.64 (0.53–0.77) | ||
Other | 0.79 (0.59–1.05) | 1.04 (0.85–1.28) | ||
Hispanic Ethnicity | 0.94 (0.77–1.15) | 0.56 | 0.73 (0.62–0.86) | <0.001 |
Medicare Insurance | 0.61 (0.48–0.77) | <0.001 | 0.70 (0.56–0.87) | 0.001 |
Admission Year | 1.07 (1.05–1.09) | <0.001 | 1.11 (1.09–1.13) | <0.001 |
2000 (reference) | ||||
2001 | 1.03 (0.81–1.33) | 0.92 (0.75–0.86) | ||
2002 | 1.12 (0.88–1.43) | 1.04 (0.86–1.27) | ||
2003 | 0.94 (0.73–1.21) | 1.14 (0.94–1.38) | ||
2004 | 1.22 (0.96–1.55) | 1.35 (1.12–1.62) | ||
2005 | 1.25 (0.99–1.58) | 1.67 (1.40–1.99) | ||
2006 | 1.55 (1.24–1.94) | 1.83 (1.53–2.18) | ||
2007 | 1.39 (1.10–1.74) | 1.71 (1.43–2.04) | ||
Length of Stay | 1.02 (1.02–1.02) | <0.001 | 1.01 (1.01–1.01) | <0.001 |
Surgerya | 2.16 (1.91–2.43) | <0.001 | 1.23 (1.12–1.35) | <0.001 |
Comorbidities | ||||
Diabetes | 1.36 (1.20–1.53) | <0.001 | 1.14 (1.03–1.25) | 0.009 |
Cancer | 1.32 (1.13–1.55) | <0.001 | 1.24 (1.09–1.42) | 0.001 |
Dementia | 1.57 (1.28–1.93) | <0.001 | 1.03 (0.87–1.21) | 0.74 |
Ulcer | 1.92 (1.49–2.47) | <0.001 | 1.31 (1.04–1.67) | 0.02 |
AIDS | 4.15 (2.02–8.50) | <0.001 | 3.27 (1.60–6.65) | 0.001 |
High Comorbidity Indexb | 1.06 (1.02–1.11) | <0.001 | 1.02 (1.01–1.03) | 0.001 |
Primary Admission Diagnosis: | ||||
Chemotherapy | 7.08 (4.04–12.42) | <0.001 | ---------------------- | |
S.aureus Pneumonia | 5.13 (3.23–8.16) | <0.001 | ---------------------- | |
Infection due to Vascular Device | 3.05 (1.87–4.97) | <0.001 | ---------------------- | |
Septicemia | 2.70 (3.71–1.96) | <0.001 | 3.55 (2.87–4.40) | <0.001 |
Post-operative Infection | 2.36 (3.89–1.43) | <0.001 | 2.39 (1.51–3.76) | <0.001 |
Acute Respiratory Failure | 2.25 (1.63 – 3.10) | <0.001 | ---------------------- | |
Pneumonia | 1.47 (1.93–1.11) | 0.006 | 1.82 (1.54–2.16) | <0.001 |
Cellulitis | ---------------------- | 2.41 (1.72–3.38) | <0.001 | |
Colon Diverticulitis | ---------------------- | 2.37 (1.64–3.43) | <0.001 | |
Urinary Tract Infection | ---------------------- | 1.86 (1.48–2.33) | <0.001 | |
Acute Renal Failure | ---------------------- | 1.73 (1.25–2.39) | <0.001 |
Surgery indicates surgery during the current admission or within the previous 30 days
Comorbidity Index measured by Romano score